Two-year follow-up results of transurethral feedback microwave thermotherapy in benign prostate hyperplasia patients with high risk factors
10.3760/cma.j.issn.1000-6702.2012.02.012
- VernacularTitle:经尿道反馈式微波治疗高危前列腺增生随访2年结果分析
- Author:
Yuhua HUANG
;
Jianquan HOU
;
Chunyin YAN
;
Duangai WEN
;
Jinxian PU
;
Jun OUYANG
;
Gang LI
;
Hexing YUAN
;
Xiang DING
- Publication Type:Journal Article
- Keywords:
Prostatic hyperplasia;
High risk;
Transurethral feedback microwave thermotherapy
- From:
Chinese Journal of Urology
2012;33(2):120-122
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect of transurethral feedback microwave thermotherapy with the ProstaLund CoreTherm Device (PLFT) in benign prostate hyperplasia ( BPH ) patients with high risk factors 24 months after treatment.MethodsSixty-two BPH cases with high risk factors of aged ≥ 80or complicating severe conditions of no less than one organ or system,were treated with PLFT under urethral local anesthesia.The average pre-treatment prostate volume,international prostate symptom score (IPSS),quality of life score (QOL) and maximal urinary flow (Qmax) were 62.03 ml,23.19,4.58 and 4.33 ml/s,respectively.The changes of prostate volume,IPSS,QOL and Qmax at 3 months,12 months and 24 months after treatment were analyzed.ResultsAll patients tolerated well of PLFT performed in common therapy room except lightly bleeding,minor infection and temporary incontinence.There was no severe surgical adverse event.After 3 months,the prostate volume reduced to 43.85 ml,IPSS decreased to 11.63,QOL decreased to 2.44,Qmax rose up to 11.44 ml/s； The average values were 45.10 ml,12.23,2.61 and 10.91ml/s at 12 months after treatment.The corresponding values were 45.80 ml,12.37,2.66 and 10.82 ml/s,respectively at 24 months after treatment.Compared with pre-treatment,all the parameters showed significant improvement ( P ＜ 0.01 ).ConclusionsPLFT is one of the effective and safe treatment options for BPH patients with high risk factors.It can be safely used on day-surgery patients.The best effect appears at 3 months after treatment.
